Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing–remitting multiple sclerosis: an observational study

OBJECTIVE: To compare outcomes after treatment with autologous haematopoietic stem cell transplantation (AHSCT) and alemtuzumab (ALZ) in patients with relapsing–remitting multiple sclerosis. METHODS: Patients treated with AHSCT (n=69) received a conditioning regimen of cyclophosphamide (200 mg/kg) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhukovsky, Christina, Sandgren, Sofia, Silfverberg, Thomas, Einarsdottir, Sigrun, Tolf, Andreas, Landtblom, Anne-Marie, Novakova, Lenka, Axelsson, Markus, Malmestrom, Clas, Cherif, Honar, Carlson, Kristina, Lycke, Jan, Burman, Joachim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Multiple Sclerosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841472/
https://www.ncbi.nlm.nih.gov/pubmed/33106366
http://dx.doi.org/10.1136/jnnp-2020-323992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841472/
https://www.ncbi.nlm.nih.gov/pubmed/33106366
http://dx.doi.org/10.1136/jnnp-2020-323992

Ejemplares similares